The Library
Urinary volatile organic compound testing in fast-track patients with suspected colorectal cancer
Tools
Tools
Tools
Boulind, Caroline E., Gould, Oliver, de Lacy Costello, Ben, Allison, Joanna, White, Paul, Ewings, Paul, Wicaksono, Alfian N., Curtis, Nathan J., Pullyblank, Anne, Jayne, David, Covington, James A., Ratcliffe, Norman, Turner, Claire and Francis, Nader K. (2022) Urinary volatile organic compound testing in fast-track patients with suspected colorectal cancer. Cancers, 14 (9). 2127. doi:10.3390/cancers14092127 ISSN 2072-6694.
|
PDF
WRAP-Urinary-volatile-organic-compound-testing-in-fast-track-patients-with-suspected-colorectal-cancer-Covington-22.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (598Kb) | Preview |
Official URL: http://dx.doi.org/10.3390/cancers14092127
Abstract
Colorectal symptoms are common but only infrequently represent serious pathology, including colorectal cancer (CRC). A large number of invasive tests are presently performed for reassurance. We investigated the feasibility of urinary volatile organic compound (VOC) testing as a potential triage tool in patients fast-tracked for assessment for possible CRC. A prospective, multi-center, observational feasibility study was performed across three sites. Patients referred to NHS fast-track pathways for potential CRC provided a urine sample that underwent Gas Chromatography-Mass Spectrometry (GC-MS), Field Asymmetric Ion Mobility Spectrometry (FAIMS), and Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) analysis. Patients underwent colonoscopy and/or CT colonography and were grouped as either CRC, adenomatous polyp(s), or controls to explore the diagnostic accuracy of VOC output data supported by an artificial neural network (ANN) model. 558 patients participated with 23 (4%) CRC diagnosed. 59% of colonoscopies and 86% of CT colonographies showed no abnormalities. Urinary VOC testing was feasible, acceptable to patients, and applicable within the clinical fast track pathway. GC-MS showed the highest clinical utility for CRC and polyp detection vs. controls (sensitivity = 0.878, specificity = 0.882, AUROC = 0.896) but it is labour intensive. Urinary VOC testing and analysis are feasible within NHS fast-track CRC pathways. Clinically meaningful differences between patients with cancer, polyps, or no pathology were identified suggesting VOC analysis may have future utility as a triage tool.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) | ||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Engineering > Engineering | ||||||||
| Library of Congress Subject Headings (LCSH): | Colon (Anatomy) -- Cancer , Colon (Anatomy) -- Cancer -- Diagnosis, Rectum -- Cancer, Volatile organic compounds | ||||||||
| Journal or Publication Title: | Cancers | ||||||||
| Publisher: | MDPI | ||||||||
| ISSN: | 2072-6694 | ||||||||
| Official Date: | 24 April 2022 | ||||||||
| Dates: |
|
||||||||
| Volume: | 14 | ||||||||
| Number: | 9 | ||||||||
| Number of Pages: | 12 | ||||||||
| Article Number: | 2127 | ||||||||
| DOI: | 10.3390/cancers14092127 | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Access rights to Published version: | Open Access (Creative Commons) | ||||||||
| Date of first compliant deposit: | 9 May 2022 | ||||||||
| Date of first compliant Open Access: | 10 May 2022 | ||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
